Biotech Values

[jq1234]

>> Another scenario is Miller did a deal to try and screw Gilead in any way he could, but ABBV did not give away the store.

That's a rationalization! It has been discussed in details on this board that both ABBV and ESRX had incentives to do this type of deal where wider access accompanied by lower price.


>> Again, we do not know the size of the discount ABBV gave. Are they stupid enough to capitulate this early in the game?

As I had pointed out before, the rational price for ABBV is less or equal to Harvoni 8-week regimen - excluding Harvoni 8-week regimen from formulary strongly supports this type of price discount agreement. Is that giving away the store or considered stupid to capitulate? I certainly don't think so! It's in ABBV's own interest.